Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$317M |
| 2 |
Walmart Inc
WMT
|
+$218M |
| 3 |
Linde
LIN
|
+$174M |
| 4 |
PayPal
PYPL
|
+$133M |
| 5 |
Union Pacific
UNP
|
+$126M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$724M |
| 2 |
Uber
UBER
|
+$527M |
| 3 |
ExxonMobil
XOM
|
+$450M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$365M |
| 5 |
Apple
AAPL
|
+$336M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.8% |
| 2 | Healthcare | 17.12% |
| 3 | Consumer Discretionary | 13.21% |
| 4 | Financials | 8.81% |
| 5 | Consumer Staples | 7.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
Natural Alternatives International
NAII
$14.6M
| $2.03M | ﹤0.01% |
333,256
-4,800
| -1% | -$29.2K |
|
2027
Cogent Biosciences
COGT
$7.32B
| $2.01M | ﹤0.01% |
299,668
+273,400
| +1,041% | +$1.69M |
|
2028
Brown-Forman Class A
BF.A
$13.2B
| $2.01M | ﹤0.01% |
37,976
-18,300
| -33% | -$1.05M |
|
|
ASRT
2029
DELISTED
Assertio
ASRT
| $2.01M | ﹤0.01% |
139,464
-70,037
| -33% | -$955K |
|
2030
ProShares Short 20+ Year Treasury ETF
TBF
$104M
| $2M | ﹤0.01% |
86,400
-53,600
| -38% | -$1.24M |
|
2031
Amylyx Pharmaceuticals
AMLX
$2.43B
| $2M | ﹤0.01% |
704,600
+633,312
| +888% | +$8.28M |
|
2032
Backblaze
BLZE
$1.19B
| $2M | ﹤0.01% |
195,616
-7,000
| -3% | -$64.7K |
|
2033
First Community Bankshares
FCBC
$924M
| $2M | ﹤0.01% |
57,794
-3,600
| -6% | -$122K |
|
2034
Chesapeake Utilities
CPK
$3.19B
| $1.99M | ﹤0.01% |
18,550
+14,500
| +358% | +$1.5M |
|
|
AAT
2035
American Assets Trust
AAT
$1.42B
| $1.98M | ﹤0.01% |
90,500
+77,100
| +575% | +$1.7M |
|
2036
State Street SPDR Bloomberg International Treasury Bond ETF
BWX
$1.31B
| $1.98M | ﹤0.01% |
88,900
+9,300
| +12% | +$208K |
|
2037
Vanguard Morningstar Mega Cap Growth ETF
MGK
$34B
| $1.98M | ﹤0.01% |
+34,495
| New | +$1.9M |
|
2038
Allot
ALLT
$401M
| $1.97M | ﹤0.01% |
873,106
-21,500
| -2% | -$40.9K |
|
|
IVAC
2039
DELISTED
Intevac Inc
IVAC
| $1.97M | ﹤0.01% |
513,577
+12,487
| +2% | +$50K |
|
|
FARM
2040
DELISTED
Farmer Brothers
FARM
| $1.97M | ﹤0.01% |
551,900
+17,300
| +3% | +$60.2K |
|
2041
10x Genomics
TXG
$6.08B
| $1.97M | ﹤0.01% |
+52,400
| New | +$2.3M |
|
|
CMRX
2042
DELISTED
Chimerix, Inc.
CMRX
| $1.97M | ﹤0.01% |
1,853,815
+291,806
| +19% | +$304K |
|
2043
iShares Global Healthcare ETF
IXJ
$4.08B
| $1.96M | ﹤0.01% |
21,036
-64
| -0.3% | -$5.79K |
|
2044
abrdn Physical Gold Shares ETF
SGOL
$6.96B
| $1.96M | ﹤0.01% |
92,200
-12,398
| -12% | -$246K |
|
2045
Ultralife
ULBI
$91.3M
| $1.96M | ﹤0.01% |
222,190
-50,774
| -19% | -$413K |
|
2046
Hancock Whitney
HWC
$6.32B
| $1.95M | ﹤0.01% |
+42,373
| New | +$1.88M |
|
2047
Fidelity MSCI Energy Index ETF
FENY
$1.97B
| $1.95M | ﹤0.01% |
75,300
+47,900
| +175% | +$1.13M |
|
2048
Dorman Products
DORM
$4.42B
| $1.95M | ﹤0.01% |
+20,200
| New | +$1.74M |
|
2049
EXL Service
EXLS
$5.21B
| $1.95M | ﹤0.01% |
+61,200
| New | +$1.9M |
|
2050
Bank of Marin Bancorp
BMRC
$478M
| $1.95M | ﹤0.01% |
115,992
+4,624
| +4% | +$84.6K |
|
Similar funds
Renaissance Technologies's Q1 2024 Portfolio in Review
As of Q1 2024, Renaissance Technologies held 4,246 positions worth $63.6B, down 1.5% from $64.6B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies withdrew a net $5.25B in Q1 2024, closing 582 positions and reducing 1,517 holdings. Its most notable exit was ExxonMobil, an estimated $450M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in Chevron worth $331M.
- Renaissance Technologies's largest Q1 2024 buy was Chevron: 2,097,623 shares worth $331M.
- Renaissance Technologies added most to Walmart Inc in Q1 2024, an estimated $218M increase.
- Renaissance Technologies's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $724M.
- Renaissance Technologies fully exited ExxonMobil in Q1 2024, selling an estimated $450M.
- Renaissance Technologies's ten largest holdings make up 12% of its $63.6B portfolio in Q1 2024.
- Renaissance Technologies opened 563 new positions and closed 582 in Q1 2024.
- Renaissance Technologies's portfolio value fell 1.5% quarter-over-quarter to $63.6B.
Based on Renaissance Technologies's 13F filing for Q1 2024, filed 13 May 2024.